TipRanks
Go Ultimate55% OFF

Jonathan Zalevsky Insider Profile

11 Followers

Jonathan Zalevsky, Chief R&D Officer at Nektar Therapeutics, holds 9.57K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Jonathan Zalevsky Sold 186 shares of Nektar Therapeutics on Aug 20, 2026 for an estimated value of $13.39K.

Jonathan Zalevsky's Trading History

NKTR
Nektar Therapeutics
Aug 20, 2026Chief R&D OfficerInformative Sell13.39K$371.99K
NKTR
Insider Shares: 9.57K (0.03%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 20, 2026Informative Sell$13.39K186$71.98+47.80%
Jul 02, 2026Uninformative Sell$397.67K5,681$70.00―
Jun 17, 2026Uninformative Sell$336.21K5,538$60.71―
May 21, 2026Informative Sell$13.04K199$65.51+43.30%
Feb 20, 2026Informative Sell$13.14K180$73.00+47.20%

You May Also Like

Jonathan Zalevsky insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Zalevsky?
The percentage of profitable transactions made by Jonathan Zalevsky is 44%.
What is the average return per transaction made by Jonathan Zalevsky?
The average return per transaction made by Jonathan Zalevsky is -80.70%.
What stocks does Jonathan Zalevsky hold?
Jonathan Zalevsky holds: NKTR stocks.
What was Jonathan Zalevsky’s latest transaction?
Jonathan Zalevsky’s latest transaction was an Informative Sell of $13.39K.
What was Jonathan Zalevsky's most profitable transaction?
Jonathan Zalevsky’s most profitable transaction was an Informative Sell of NKTR stock on November 18, 2022. The return on the trade was 86.20%.
What is Jonathan Zalevsky's role in Nektar Therapeutics?
Jonathan Zalevsky's role in Nektar Therapeutics is Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.